Alain Milot

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

Kara Nerenberg, Kelly B. Zarnke, Alexander A. C. Leung et al. · Canadian Journal of Cardiology · 2018 · 584 citations · Full text

Medicine, Cardiology, Pediatrics +13

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Alexander A. C. Leung, Kara Nerenberg, Stella S. Daskalopoulou et al. · Canadian Journal of Cardiology · 2016 · 470 citations

Medicine, Cardiology, Preventive Medicine +14

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

Alexander A. C. Leung, Stella S. Daskalopoulou, Kaberi Dasgupta et al. · Canadian Journal of Cardiology · 2017 · 322 citations

Medicine, Cardiology, Preventive Medicine +14